Spotlight on HS With Dr. Martina Porter

November 7, 2025

In Their Own Words: HS Patients Share Their Truths in New Incyte Campaign

September 4, 2025

Pearls for HS Management With Dr. Steve Daveluy

August 14, 2025

News Your HS Patients Can Use: UCB Expands “Get Yourself Back” DTC Campaign for Bimekizumab

July 8, 2025

Surgical Deroofing in HS: How, When, and Why?

March 14, 2025

New Dosing Option for UCB’s Bimekizumab Now Commercially Available for PsO, PsA, and HS Patients

January 16, 2025

A Future Dermatologist’s Journey With HS

December 2, 2024

Expert Perspective: What Does the Approval of Bimekizumab-bkzx (Bimzelx, UCB) Mean for The HS Community?

November 22, 2024

U.S. FDA Gives Its Nod to Bimekizumab-bkzx (Bimzelx, UCB) for HS

November 20, 2024

Does Semaglutide Improve Outcomes for Obese Patients With HS?

September 24, 2024

The Patient Perspective: How to Build a Rapport With HS Patients

August 29, 2024

Treating HS in 2024 and Beyond

August 26, 2024